Thu, Jul 24, 2014, 10:16 AM EDT - U.S. Markets close in 5 hrs 44 mins

Recent

% | $
Click the to save as a favorite.

Endocyte, Inc. (ECYT) Message Board

  • paintball_is_stellar paintball_is_stellar Jan 21, 2014 8:09 AM Flag

    Oral Presentation

    Does anyone know if the CHMP can approve off of an oral presentation or will this thing get tied up a little longer?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The meeting today will allow the CHMP and the assigned reviewers to have their specific questions (based on ECYT's documentation thus far) to be addressed. At this stage the outcome could have been 1. rejection of application. no more data could have saved it. 2. No more clarifications necessary, can go to CHMP meeting for a vote. 3. Additional outstanding questions need to be addressed before a positive opinion can be rendered. It is understood that if ECYT can address the question satisfactorily, it has a good chance to be approved.

      So this is good news, I think. Once the oral or written address to the questions has been pondered by teh CHMP members, they will vote on it. The earliest that will be is at the next month's meeting, though it could slip another month. At that point it is thumbs up or down. If up, it will be a few more months to get it officially approved.

      I'm hopeful!!

      Sentiment: Strong Buy

    • CHMP does not have approval authority so no approval or disapproval will come out of this meeting. They will issue an "opinion" and you won't hear about it until the minutes of the meeting are released. That is typically about two weeks after the meeting but they have been running behind. If they issue a positive opinion the final opinion can be out to day 277 or another several months. A positive opinion is what we are seeking here.

    • oral (or written )!!!!!!!!!!! explanation!!!!! that i think endocyte have do !!!!

      MaRS Copyright © 2010
      Accelerated assessment
      In cases where products are considered to be of major public health interest, a sponsor can apply for accelerated
      assessment of their application. If granted, the 210-day review procedure is shortened to 150 days.
      Committee request for additional information
      Once the CHMP has the preliminary assessment reports or critique from the rapporteur and co-rapporteur, it
      prepares a list of any outstanding issues the sponsor must address. A consolidated list of questions identifying
      “other concerns” and/or “major objections” is prepared. These are sent to the sponsor with the CHMP
      recommendation and scientific discussion. The clock will then be stopped (day 120).
      The CHMP can make one of two recommendations:
      1. The product could be approved provided that satisfactory answers are given to “other concerns,” and that the
      indications, the elements of the summary of product characteristics, and other conditions for marketing are
      amended as outlined in the list of questions.
      2. The product is not approvable since there are “major objections.”
      The sponsor has three months from the date of receiving the questions to respond to the CHMP. Sponsors are
      permitted to request a three-month extension, if required.
      Oral (or written) explanation
      The CHMP will discuss the joint-assessment report and comments of other CHMP members. The CHMP may identify
      additional issues which the sponsor must address in writing or during an oral explanation. If a sponsor wishes to
      make an oral presentation, it usually has one month to prepare.
      After the oral explanation and the subsequent CHMP discussion, the rapporteur will provide feedback to the
      sponsor before a formal vote takes place. If the outcome appears it will be positive, a discussion may be held
      regarding key amendments to the product characteristics summary and draft follow-up measures or conditions

    • Looking at5 the Dec agaenda and then the meeting hoghlights it looks like you need to get to the New Applications portion of the meeting before you get a decision. Since ECYT is on the Preautorizations Procedure Oral EWxplanations it looks to be another month at least before we see a decision. Of course that's just my opinion and I could be wrong.

      Sentiment: Hold

    • nferna@parknet.pmh.org nferna Jan 21, 2014 8:24 AM Flag

      I would also like to know if this means a push back to a future meeting.

      Also, for the regulatory gurus out there, in the case of an oral presentation like this, is Endocyte allowed to bring advisors from Merck with them? If present, are these advisors allowed a speaking role? Or is Endocyte fending for themselves?

    • Has it been confirmed (from a reliable source) that ECYT will, in fact, be making an oral presentation?

 
ECYT
6.32+0.08(+1.28%)10:16 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.